Clinical trial
The Silent Saboteur: The Impact of Headaches on Sleep Disorders, Central Sensitization, Depression, Anxiety and Stress
NCT06603493 is registered in ClinicalTrials.gov with Nagihan Acet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Silent Saboteur: The Impact of Headaches on Sleep Disorders, Central Sensitization, Depression, Anxiety and Stress
- Lead sponsor
- Nagihan Acet
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 19, 2024
- Completion date
- December 19, 2024
- Enrollment
- 132 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
headache disorder